Vasculitis syndromes: Inducing remission in ANCA-positive vasculitis: Time to RAVE?

Nature Reviews Rheumatology

Volumn 6, Issue 3, 2010, Pages 127-128

  Watts, Richard A ^a  

^a IPSWICH HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; METHOTREXATE; METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PLACEBO; PREDNISOLONE; RITUXIMAB;

ANCA ASSOCIATED VASCULITIS; B LYMPHOCYTE; BLADDER CANCER; CLINICAL TRIAL; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG COST; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG SAFETY; FEMALE INFERTILITY; HEMORRHAGIC CYSTITIS; HUMAN; INFECTION; INFECTION RISK; INFERTILITY; LYMPHOCYTE DEPLETION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RELAPSE; REMISSION; SHORT SURVEY;

ADMINISTRATION, ORAL; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, MONOCLONAL; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOLOGIC FACTORS; INJECTIONS, INTRAVENOUS; METHYLPREDNISOLONE; MULTICENTER STUDIES AS TOPIC; PREDNISOLONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX;

EID: 77749270424     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2010.19     Document Type: Short Survey

References (8)

1. Sneller, M. C. Rituximab and wegener's granulomatosis: are B cells a target in vasculitis treatment? Arthritis Rheum. 52, 1-5 (2005).
2. Stone, J. H. et al. Rituximab versus cyclophosphamide for induction of remission in AnCA-associated vasculitis: a randomized controlled trial (RAVE) [abstract 550]. Arthritis Rheum. 60 (suppl.), S204 (2009).
3. Mukhtyar, C. et al. EULAR recommendations for the management of primary small and medium vasculitis. Ann. Rheum. Dis. 68, 310-317 (2009).
4. Jayne, D. et al. A randomized trial of maintenance therapy for vasculitis associated with anti-neutrophil cytoplasmic antibodies. N. Engl. J. Med. 349, 36-44 (2003).
5. de Groot, K. et al. Pulse versus daily oral cyclophosphamide for induction of remission in anti-neutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann. Intern. Med. 150, 670-680 (2009).
6. de Groot, K. et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 52, 2462-2468 (2005).
7. Major, E. O. Progressive multifocal leukoencephalopathy in patients on biologic therapies. Ann. Rev. Med. 61, 35-47 (2010).
8. Salliot, C., Dougados, M. & Gossec, L. Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials. Ann. Rheum. Dis. 68, 25-32 (2009).